Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
26
NMPA:12
PHILIPPINES:11
SFDA:3
Drug Approvals
Mesalazine Sustained-release Tablets
- Product Name
- 颇得斯安
- Approval Number
- 国药准字HJ20181183
- Approval Date
- Mar 20, 2023
NMPA
Highly Purified Menotrophin for Injection
- Product Name
- 贺美奇
- Approval Number
- 国药准字HJ20181224
- Approval Date
- Jan 18, 2023
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found